Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients

Journal of Nephrology

Volumn 18, Issue 5, 2005, Pages 559-567

  Uslu, Sema ^a   Efe, Belgin ^a   Alataş, Özkan ^a   Kebapçi, Nur ^a   Çolak, Ömer ^a   Demirüstü, Canan ^a   Yörük, Ayşe ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Cystatin C; Diabetes mellitus; Urinary enzymes

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; CYSTATIN C; HEMOGLOBIN A1C; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYMURIA; FEMALE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METABOLIC REGULATION; MICROALBUMINURIA; PLOTS AND CURVES; PROTEIN BLOOD LEVEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS; UROGENITAL SYSTEM PARAMETERS;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; AGED; ALBUMINURIA; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; ENZYME TESTS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED;

EID: 29244472811     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Keevil BG, Kilpatrick ES, Nichols SP, Mayol PW. Biological variations of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-9.
2. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med 1999; 37: 389-95.
3. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 (suppl): S20-7.
4. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-8.
5. Tian S, Kusano E, Ohara T, Tabel K, Itoh Y, Kawai T, Asano Y. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48: 104-8.
6. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34.
7. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003; 12: 639-43.
8. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabet Complications 1998; 12: 43-60.
9. Flynn FV. Assessment of renal function: Selected developments. Clin Biochem 1990; 23: 49-53.
10. Turecky L, Uhlikova E. Diagnostic significance of urinary enzymes in nephrology. Bratisl Lek Listy 2003; 104: 27-31.
11. Price RG. Measurement of N-acetyl-b-glucoseaminidase and its isoenzymes in urine: methods and clinical applications. Eur J Clin Chem Clin Biochem 1992; 30: 693-705.
12. Jung K. Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction. Kidney Int 1994; 46 (supp 47): S29-33.
13. Jung K, Pergande M, Wischke UW. Characterization of particulate and soluble variants of the brush-border enzymes alanine aminopeptidase, alkaline phosphatase and gamma-glutamyl transferase in human urine. Biomed Biochim Acta 1984; 43: 1357-64.
14. Mussap M, Vestra MD, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than serum creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-61.
15. Tan GD, Lewis AV, James TJ, Altmann P, Taylor RP, Levy JC. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes. Diabetes Care 2002; 25: 2004-9.
16. Mojiminiyi OA, Abdella N. Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J. Diabet Complications 2003; 17: 160-8.
17. Harmoinen AP, Kouri TT, Wirta OR, Lehtimaki TJ, Rantalaiho V, Turjanmaa VM, Pasternack AI. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1999; 52: 363-70.
18. Buysschaert M, Joudi I, Wallemacq P, Hermans MP. Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes. Diabetes Care 2003; 26: 1320.
19. Piwowar A, Knapik-Kordecka M, Buczynska H, Warnas M. Plasma cystatin C concentration in non-Insulin-dependent diabetes mellitus: relation with nephropathy. Arch Immunol Ther Exp 1999; 47: 327-31.
20. Aksun SA, Ozmen D, Ozmen B, Parildar Z, Mutaf I, Turgan N, Hakan S, Kumanliogluc K, Bayindir O. Beta-2 microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2004; 112: 195-200.
21. Shimizu A, Horikoshi S, Rinno H, Kobata M, Saito Ki Tomino Y. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal 2003; 17: 164-7.
22. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-31.
23. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
24. Perlemoine C, Beauvieux M-C, Rigalleau V, Baillet L, barthes N, Darache P, Gin H. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism 2003; 52: 1258-64.
25. Rosenthal SH, Poppen D, Hüsing J, Marggraf G, Pietruck F, Jakob HG, Philipp T, Kribben A. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50: 552-8.
26. Dedov I, Mukhin NA, Pal'tsev MA, Delektorskaia LN, Shestakova MV. Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy. Ter Arkh 1989; 61: 73-6.
27. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
28. Ha H, Lee HB. Oxidative stress in diabetic nephropathy: basic and clinical information. Curr Diab Rep 2001; 1: 282-7.
29. Yagoob M, Patric AW, McClelland P, Stavenson A, Mason H, White MC, Bell GM. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci (Lond) 1993; 85: 557-62.
30. Ishii N, Ogawa Z, Itoh H, Ikenaga H, Saruta T. Effect of proximal tubular glucose transport blockade on urinary enzyme excretions in hyperglycemic rats. Enzyme Protein 1995; 48: 43-50.
31. Ishii N, Ikenaga H, Ogawa Z, Aoki Y, Saruta T, Suga T. Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats. Ann Clin Biochem 2001; 38: 391-8.
32. Jung K, Pergande M, Schimke E, Ratzmann KP, Ilius A. Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy. Clin Chem 1988; 34: 544-7.
33. Morita E, Kaizu K, Uriu K, Hashimoto O, Komine N, Eto S. Clinical significance of urinary enzymes in diabetic nephropathy. J Diabet Complications 1991; 5: 158-9.
34. Perez-Blanco FJ, Sabatel-Harnandez G, Cantero-Hinojosa J, Rodriguez-Cuertero A. Urinary N-acetyl-β-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy. Clin Nephrol 1998; 49: 132-4.
35. Golov KG, Varshavskii VA, Okunev DI, Neverov NI, Shestakova MV. Urinary enzymes in the assessment of early stage of kidney involvement in psoriasis and diabetes mellitus. Ter Arkh 1995; 67: 80-1.
36. Chouinard S, Viau C, Greselin E. Enzymuria and tubular proteinuria in diabetic rats: a 12-week follow-up study. Ren Fail 1992; 14: 41-7.
37. Limaye PV, Sivakami S. Evaluation of the fluidity and functionality of the renal cortical brush border membrane in experimental diabetes in rats. Int J Biochem Cell Biol 2003; 35: 1163-9.
38. Nuyts GD, Yagoop M, Nouwen EJ, Patrick AW, McClelland P, MacFarlane IA, Bell GM, De Broe ME. Human urinary intestinal alkaline phosphatase as a indicator of S3 segment specific alterations in incipient diabetic nephropathy. Nephrol Dial Transplant 1994; 9: 377-81.
39. Nouwen EJ, De Broe ME. Human intestinal versus tissue-nonspecific alkaline phosphatase as complementary urinary markers for the proximal tubule. Kidney Int Suppl 1994; 47: S43-51.
40. Kowluru RA, Abbas SN, Odenbach S. Reversal of hyperglycemia and diabetic nephropathy effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabet Complications 2004; 18: 282-8.
41. Lepore G, Bruttomesso D, Nosari I, Tiengo A, Travisan R. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Diabetes Nutr Metab 2002; 15: 232-9.
42. Watts GF, Vlitos MA, Morris RW, Price RG. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control. Diabete Metab 1988; 14: 653-8.
43. Oba K, Igari Y, Matsumura N, Watanabe K, Inuzuka Y, Ajiro Y, Okazaki K, Sato S, Suzuki T, Nakano H, Metori S. Effects of control of blood glucose on urinary N-acetyl-β-glucosaminidase in elderly type 2 diabetes mellitus. J Nippon Med Sch 2000, 67: 143-5.
44. Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta T. Enzymuria in non-insulin-dependent patients: sings of tubular cell dysfunction. Clin Sci 1993; 84: 469-75.
45. Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal 2004; 18: 31-5.